David J. Gnarra

566 total citations
14 papers, 405 citations indexed

About

David J. Gnarra is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, David J. Gnarra has authored 14 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Genetics and 6 papers in Immunology. Recurrent topics in David J. Gnarra's work include Platelet Disorders and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). David J. Gnarra is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). David J. Gnarra collaborates with scholars based in United States, Canada and Tunisia. David J. Gnarra's co-authors include Kun Nie, George R. Buchanan, James B. Bussel, Diane J. Nugent, Victor S. Blanchette, Lisa Bomgaars, Peter F. Coccia, Bruce G. Gordon, Beatrice C. Lampkin and Melissa Eisen and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer.

In The Last Decade

David J. Gnarra

13 papers receiving 392 citations

Peers

Countries citing papers authored by David J. Gnarra

Since Specialization

Citations

This map shows the geographic impact of David J. Gnarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Gnarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Gnarra more than expected).

Fields of papers citing papers by David J. Gnarra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Gnarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Gnarra. The network helps show where David J. Gnarra may publish in the future.

Co-authorship network of co-authors of David J. Gnarra

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Gnarra. A scholar is included among the top collaborators of David J. Gnarra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Gnarra. David J. Gnarra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP) 2014 ·Pediatric Blood & Cancer ·James B. Bussel, Loan Hsieh, George R. Buchanan, Kimo C. Stine, Ram Kalpatthi, David J. Gnarra, Richard Ho, Kun Nie, Melissa Eisen	47
2	Long-Term Use of Open-Label Romiplostim in Children with Chronic/Refractory Immune Thrombocytopenia (ITP) 2012 ·Blood ·James B. Bussel, George R. Buchanan, David J. Gnarra, Richard Ho, Kun Nie, Melissa Eisen	0
3	A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia 2011 ·Blood ·James B. Bussel, George R. Buchanan, Diane J. Nugent, David J. Gnarra, Lisa Bomgaars, Victor S. Blanchette, (unknown), Kun Nie, (unknown)	157
4	Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS) 2009 ·Pediatric Blood & Cancer ·V. Koneti Rao, Susan Price, Katie Perkins, (unknown), (unknown), Joie Davis, Janet K. Dale, Fred A. Gill, Kip R. Hartman, Linda C. Stork, David J. Gnarra, Lakshmanan Krishnamurti, Peter E. Newburger, Jennifer M. Puck, Thomas A. Fleisher	58
5	A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim in Children with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP). 2009 ·Blood ·George R. Buchanan, Lisa Bomgaars, James B. Bussel, Diane J. Nugent, David J. Gnarra, Victor S. Blanchette, Kun Nie, Melissa Eisen, Dietmar Berger	4
6	Pulmonary Embolism in an Adolescent Soccer Player 2007 ·Medicine & Science in Sports & Exercise ·Kody Moffatt, (unknown), David J. Gnarra	10
7	Use of Rituximab for Refractory Immune Cytopenias Associated with Autoimmune Lymphoproliferative Syndrome (ALPS). 2007 ·Blood ·Janet K. Dale, Susan Price, (unknown), (unknown), (unknown), Joie Davis, Fred A. Gill, Kip R. Hartman, Linda C. Stork, David J. Gnarra, Lakshmanan Krishnamurti, Jennifer M. Puck, Thomas A. Fleisher, V. Koneti Rao	1
8	Peripheral T-cell lymphoma in childhood and adolescence a clinicopathologic study of 22 patients 1993 ·Cancer ·Bruce G. Gordon, Dennis D. Weisenburger, Phyllis I. Warkentin, James R. Anderson, Warren G. Sanger, Martin Bast, David J. Gnarra, Julie M. Vose, (unknown), Jamés O. Armitage, Peter F. Coccia	38
9	Acute lymphoblastic leukemia of NK-cell lineage: Responses to IL-2 1989 ·Leukemia Research ·Samuel J. Pirruccello, (unknown), Bruce G. Gordon, Kazimiera J. Gajl‐Peczalska, David J. Gnarra, Peter F. Coccia	23
10	Benign glandular inclusions. 1985 ·PubMed ·Tishan Williams, D D Weisenburger, David J. Gnarra	8
11	Evaluation of 24-hour infusion of high-dose methotrexate ?Pharmacokinetics and toxicity 1979 ·Cancer Chemotherapy and Pharmacology ·(unknown), Kwan Y. Wong, Beatrice C. Lampkin, James J. O’Leary, David J. Gnarra	14
12	HEPATOMA ASSOCIATED WITH ANABOLIC STEROID THERAPY 1975 ·American Journal of Roentgenology ·Lawrence E. Holder, David J. Gnarra, Beatrice C. Lampkin, Hiroshi Nishiyama, (unknown)	21
13	Hemoglobin Abraham Lincoln, β32 (B14) Leucine → Proline AN UNSTABLE VARIANT PRODUCING SEVERE HEMOLYTIC DISEASE 1973 ·Journal of Clinical Investigation ·George R. Honig, David Green, Mir Shamsuddin, Loyda N. Vida, R. G. Mason, David J. Gnarra, Helen S. Maurer	22
14	AN UNSTABLE VARIANT PRODUCING SEVERE HEMOLYTIC DISEASE 1973 ·George R. Honig, David Green, Mir Shamsuddin, Loyda N. Vida, David J. Gnarra, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact